Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2b, DB, Randomized Study Evaluating Efficacy & Safety of Sorafenib Compared With Placebo When Administered in Combination With Modified FOLFOX6 for the Treatment of Metastatic CRC Subjects Previously Untreated for Stage IV Disease

NCT00865709 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00865709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00865709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2b, DB, Randomized Study Evaluating Efficacy & Safety of Sorafenib Compared With Placebo When Administered in Combination With Modified FOLFOX6 for the Treatment of Metastatic CRC Subjects Previously Untreated for Stage IV Disease
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
February 29, 2012
Enrollment
198 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer